SZSE:300204 (China)
Â
Class A
Â¥
6.45
(+0.94%)
May 24
Business Description
Staidson (Beijing) Biopharmaceuticals Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE100001237
Share Class Description:
SZSE:300204: Class ACompare
Compare
Traded in other countries / regions
300204.China IPO Date
2011-04-15Description
Staidson (Beijing) Biopharmaceuticals Co Ltd is a pharmaceutical company mainly engaged in the research, development, production, and sale of biological products in China. Its products include mouse nerve growth factor injection, intravenous compound polyethylene glycol electrolyte powder solution, gliclazide, nabumetone, and aspirin.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.19 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.09 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 5.78 | |||||
| Beneish M-Score | -3.51 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -5 | |||||
| 3-Year EBITDA Growth Rate | -38.8 | |||||
| 3-Year EPS without NRI Growth Rate | -40 | |||||
| 3-Year FCF Growth Rate | -16.9 | |||||
| 3-Year Book Growth Rate | -13.8 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.7 | |||||
| 9-Day RSI | 45.15 | |||||
| 14-Day RSI | 46.87 | |||||
| 6-1 Month Momentum % | -49.83 | |||||
| 12-1 Month Momentum % | -46.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.13 | |||||
| Quick Ratio | 1.02 | |||||
| Cash Ratio | 0.32 | |||||
| Days Inventory | 140.29 | |||||
| Days Sales Outstanding | 69.6 | |||||
| Days Payable | 328.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | -0.95 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 82.3 | |||||
| Operating Margin % | -79.22 | |||||
| Net Margin % | -89.8 | |||||
| FCF Margin % | -57.98 | |||||
| ROE % | -30.9 | |||||
| ROA % | -24.58 | |||||
| ROIC % | -28.61 | |||||
| ROC (Joel Greenblatt) % | -114.53 | |||||
| ROCE % | -26.01 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 100.49 | |||||
| PS Ratio | 7.26 | |||||
| PB Ratio | 2.99 | |||||
| Price-to-Tangible-Book | 3.41 | |||||
| EV-to-EBIT | -9.52 | |||||
| EV-to-EBITDA | -9.52 | |||||
| EV-to-Revenue | 7.73 | |||||
| EV-to-FCF | -13.34 | |||||
| Price-to-Median-PS-Value | 0.86 | |||||
| Earnings Yield (Greenblatt) % | -10.5 | |||||
| FCF Yield % | -7.42 | |||||
| Forward Rate of Return (Yacktman) % | -18.44 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Staidson (Beijing) Biopharmaceuticals Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 394.141 | ||
| EPS (TTM) (Â¥) | -0.75 | ||
| Beta | 1.84 | ||
| Volatility % | 32.62 | ||
| 14-Day RSI | 46.87 | ||
| 14-Day ATR (Â¥) | 0.334845 | ||
| 20-Day SMA (Â¥) | 6.6345 | ||
| 12-1 Month Momentum % | -46.67 | ||
| 52-Week Range (Â¥) | 5.44 - 13.33 | ||
| Shares Outstanding (Mil) | 477.77 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Staidson (Beijing) Biopharmaceuticals Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Staidson (Beijing) Biopharmaceuticals Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Staidson (Beijing) Biopharmaceuticals Co Ltd Frequently Asked Questions
What is Staidson (Beijing) Biopharmaceuticals Co Ltd(SZSE:300204)'s stock price today?
The current price of SZSE:300204 is ¥6.45. The 52 week high of SZSE:300204 is ¥13.33 and 52 week low is ¥5.44.
When is next earnings date of Staidson (Beijing) Biopharmaceuticals Co Ltd(SZSE:300204)?
The next earnings date of Staidson (Beijing) Biopharmaceuticals Co Ltd(SZSE:300204) is .
Does Staidson (Beijing) Biopharmaceuticals Co Ltd(SZSE:300204) pay dividends? If so, how much?
Staidson (Beijing) Biopharmaceuticals Co Ltd(SZSE:300204) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers